Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares conducted on March 25, 2026. The filing was submitted on March 26, 2026. GSK is a global biopharma company headquartered in London, England.
Key Financial Metrics and Transaction Details
The filing details a specific share repurchase transaction executed under an existing buyback programme via a non-discretionary agreement with BNP Paribas SA.
- Date of Purchase: March 25, 2026
- Shares Purchased: 345,000 ordinary shares
- Price Range: Lowest 1,988.50p; Highest 2,047.00p
- Volume-Weighted Average Price (VWAP): 2,033.20p
- Trading Venues: London Stock Exchange (XLON), CHIX, and BATE
- Treasury Share Holdings: 254,747,615 shares (post-transaction)
- Shares in Issue: 4,061,428,663 (excluding Treasury shares)
- Treasury Voting Rights: 6.27% of total voting rights
Material Changes and Programme Progress
Since the commencement of the current non-discretionary agreement on February 17, 2026, GSK has purchased a total of 14,856,521 ordinary shares. The transaction reported herein represents the latest activity within this programme. The purchased shares are held as Treasury shares and do not carry voting rights.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, revenue outlook, or management commentary regarding operational performance. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties, referencing the "Risk Factors" section of GSK's Annual Report on Form 20-F for 2025.
Investor Verification Checklist
- Verify the total remaining authorization under the current buyback programme announced on February 17, 2026.
- Confirm the impact of the 6.27% treasury holding on earnings per share (EPS) calculations.
- Review the "Risk Factors" in the 2025 Form 20-F for context on the company's broader financial risks.
- Monitor subsequent filings for updates on the completion or extension of the non-discretionary buyback agreement.